Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Apr 1.

Published in final edited form as: Int J Cancer. 2014 Aug 22;136(7):1688–1696. doi: 10.1002/ijc.29132

Figure 3A. (a) Geminin and Ki67 immunohistochemistry images of the control and glioma treated with gemcitabine. (b) The results expressed as the % geminin positive/%Ki67 positive; n = 2–4 (Mean ± SD).

Figure 3B. Typical diffusion images used to assess volume and apparent diffusion coefficient of water (ADC) of orthotropic U251 glioma on days 1 and 8 in the control, gemcitabine, MK-8776 and gemcitabine + MK-8776 groups by MRI. The implantable resonators are visible in the images of the control group (indicated by arrows).

Figure 3A. (a) Geminin and Ki67 immunohistochemistry images of the control and glioma treated with gemcitabine. (b) The results expressed as the % geminin positive/%Ki67 positive; n = 2–4 (Mean ± SD).

Figure 3B. Typical diffusion images used to assess volume and apparent diffusion coefficient of water (ADC) of orthotropic U251 glioma on days 1 and 8 in the control, gemcitabine, MK-8776 and gemcitabine + MK-8776 groups by MRI. The implantable resonators are visible in the images of the control group (indicated by arrows).